It seems that for renal cell carcinoma, postoperative serum CRP titers and kinetics hold the most predictive values, and regarding bladder cancer, CRP has been linked to disease progression in non-muscle invasive bladder cancer and to the stage of and survival for muscle invasive bladder cancer [836]. This evidence concerns the gene CRP and urinary bladder cancer.